Tejasav S. Sehrawat

10.0k total citations
27 papers, 948 citations indexed

About

Tejasav S. Sehrawat is a scholar working on Epidemiology, Hepatology and Pathology and Forensic Medicine. According to data from OpenAlex, Tejasav S. Sehrawat has authored 27 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 15 papers in Hepatology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Tejasav S. Sehrawat's work include Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (11 papers) and Alcohol Consumption and Health Effects (7 papers). Tejasav S. Sehrawat is often cited by papers focused on Liver Disease Diagnosis and Treatment (17 papers), Liver Disease and Transplantation (11 papers) and Alcohol Consumption and Health Effects (7 papers). Tejasav S. Sehrawat collaborates with scholars based in United States, China and India. Tejasav S. Sehrawat's co-authors include Vijay H. Shah, Sheng Cao, Mengfei Liu, Patrick S. Kamath, Enis Kostallari, Usman Yaqoob, Juan Pablo Arab, Jinhang Gao, Mengfei Liu and Douglas A. Simonetto and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Tejasav S. Sehrawat

26 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tejasav S. Sehrawat United States	14	560	328	265	189	143	27	948
Sander Lefere Belgium	18	789 1.4×	391 1.2×	274 1.0×	84 0.4×	213 1.5×	55	1.2k
Massih Ningarhari France	8	480 0.9×	227 0.7×	206 0.8×	95 0.5×	183 1.3×	22	801
Wilhelmus J. Kwanten Belgium	18	1.0k 1.8×	375 1.1×	186 0.7×	122 0.6×	356 2.5×	33	1.3k
Bharath Nath United States	12	318 0.6×	199 0.6×	255 1.0×	176 0.9×	59 0.4×	15	875
Kengo Kawai Japan	11	342 0.6×	181 0.6×	130 0.5×	78 0.4×	94 0.7×	26	584
Rie Irie Japan	14	390 0.7×	285 0.9×	186 0.7×	52 0.3×	119 0.8×	56	827
Narcissus Teoh Australia	12	529 0.9×	323 1.0×	361 1.4×	57 0.3×	177 1.2×	17	1.1k
Giusi Marrone Spain	10	773 1.4×	717 2.2×	274 1.0×	74 0.4×	96 0.7×	12	1.2k
Sara Aleffi Italy	10	550 1.0×	324 1.0×	148 0.6×	51 0.3×	97 0.7×	14	803
Tarek Tamimi United States	6	1.1k 2.0×	637 1.9×	159 0.6×	217 1.1×	377 2.6×	17	1.3k

Countries citing papers authored by Tejasav S. Sehrawat

Since Specialization

Citations

This map shows the geographic impact of Tejasav S. Sehrawat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tejasav S. Sehrawat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tejasav S. Sehrawat more than expected).

Fields of papers citing papers by Tejasav S. Sehrawat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tejasav S. Sehrawat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tejasav S. Sehrawat. The network helps show where Tejasav S. Sehrawat may publish in the future.

Co-authorship network of co-authors of Tejasav S. Sehrawat

This figure shows the co-authorship network connecting the top 25 collaborators of Tejasav S. Sehrawat. A scholar is included among the top collaborators of Tejasav S. Sehrawat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tejasav S. Sehrawat. Tejasav S. Sehrawat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parthasarathy, Gopanandan, Myeong Jun Song, Fanta Barrow, et al.. (2025). Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH. Hepatology Communications. 9(2). 1 indexed citations

Gupta, Vikas, Tejasav S. Sehrawat, Massimo Pinzani, & Mario Strazzabosco. (2024). Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities. Gastroenterology. 168(4). 675–690. 5 indexed citations

Saraswathi, Viswanathan, et al.. (2024). A Pilot Study on the Proteomics Profile of Serum Exosome-Enriched Extracellular Vesicles from Normal versus Individuals with Obesity-Related Insulin Resistance. Biomedicines. 12(4). 799–799. 3 indexed citations

Gan, Can, Usman Yaqoob, Nidhi Jalan‐Sakrikar, et al.. (2024). Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV–driven sinusoidal remodeling. JCI Insight. 9(11). 7 indexed citations

Barrow, Fanta, Yasuhiko Nakao, Amy S. Mauer, et al.. (2023). Modulating sphingosine 1-phosphate receptor signaling skews intrahepatic leukocytes and attenuates murine nonalcoholic steatohepatitis. Frontiers in Immunology. 14. 1130184–1130184. 9 indexed citations

Avitabile, Emma, Alba Díaz, Carla Montironi, et al.. (2023). Adding Inflammatory Markers and Refining National Institute on Alcohol Abuse and Alcoholism Criteria Improve Diagnostic Accuracy for Alcohol-associated Hepatitis. Clinical Gastroenterology and Hepatology. 21(12). 3080–3088.e9. 7 indexed citations

Sehrawat, Tejasav S., et al.. (2022). Epigenetics of alcohol-related liver diseases. JHEP Reports. 4(5). 100466–100466. 21 indexed citations

Greuter, Thomas, Usman Yaqoob, Can Gan, et al.. (2022). Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo. Journal of Hepatology. 77(3). 723–734. 59 indexed citations

Sehrawat, Tejasav S., Nidhi Jalan‐Sakrikar, Nicholas Pirius, et al.. (2021). Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex. Journal of Hepatology. 76(4). 921–933. 30 indexed citations

10.

Bajaj, Jasmohan S., Guadalupe García‐Tsao, K. Rajender Reddy, et al.. (2021). Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis. Hepatology. 74(5). 2699–2713. 36 indexed citations

11.

Acharya, Chathur, Tejasav S. Sehrawat, Deborah B. McGuire, et al.. (2021). Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study. Journal of Medical Internet Research. 23(4). e24639–e24639. 8 indexed citations

12.

Cao, Sheng, Mengfei Liu, Tejasav S. Sehrawat, & Vijay H. Shah. (2021). Regulation and functional roles of chemokines in liver diseases. Nature Reviews Gastroenterology & Hepatology. 18(9). 630–647. 73 indexed citations

13.

He, Li, Tejasav S. Sehrawat, Vikas Verma, et al.. (2021). XIAP Knockdown in Alcohol-Associated Liver Disease Models Exhibits Divergent in vitro and in vivo Phenotypes Owing to a Potential Zonal Inhibitory Role of SMAC. Frontiers in Physiology. 12. 664222–664222. 5 indexed citations

14.

Nakao, Yasuhiko, Pouya Amrollahi, Gopanandan Parthasarathy, et al.. (2021). Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery. Nanomedicine Nanotechnology Biology and Medicine. 36. 102430–102430. 46 indexed citations

15.

Bajaj, Jasmohan S., K. Rajender Reddy, Jacqueline G. O’Leary, et al.. (2020). Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Gastroenterology. 159(5). 1715–1730.e12. 81 indexed citations

16.

Yaqoob, Usman, Fanghong Luo, Thomas Greuter, et al.. (2020). GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway. Cellular and Molecular Gastroenterology and Hepatology. 10(3). 545–559. 21 indexed citations

17.

Li, Jiahui, Tejasav S. Sehrawat, Jingbiao Chen, et al.. (2020). Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models. European Radiology. 31(4). 2303–2311. 5 indexed citations

18.

Gao, Jinhang, Bo Wei, Mengfei Liu, et al.. (2020). Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling. Hepatology. 73(6). 2468–2483. 69 indexed citations

19.

Arab, Juan Pablo, Tejasav S. Sehrawat, Douglas A. Simonetto, et al.. (2019). An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis. Hepatology. 72(2). 441–453. 143 indexed citations

20.

Gupta, Yashdeep, et al.. (2015). Depression among patients with diabetes mellitus in North India evaluated using patient health questionnaire-9. Indian Journal of Endocrinology and Metabolism. 19(2). 252–252. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact